You can:
Name | Alpha-2A adrenergic receptor |
---|---|
Species | Homo sapiens (Human) |
Gene | ADRA2A |
Synonym | alpha2D alpha2A-AR alpha2A-adrenoceptor alpha2A-adrenergic receptor alpha2A [ Show all ] |
Disease | Attention deficit hyperactivity disorder Sexual dysfunction Pain |
Length | 450 |
Amino acid sequence | MGSLQPDAGNASWNGTEAPGGGARATPYSLQVTLTLVCLAGLLMLLTVFGNVLVIIAVFTSRALKAPQNLFLVSLASADILVATLVIPFSLANEVMGYWYFGKAWCEIYLALDVLFCTSSIVHLCAISLDRYWSITQAIEYNLKRTPRRIKAIIITVWVISAVISFPPLISIEKKGGGGGPQPAEPRCEINDQKWYVISSCIGSFFAPCLIMILVYVRIYQIAKRRTRVPPSRRGPDAVAAPPGGTERRPNGLGPERSAGPGGAEAEPLPTQLNGAPGEPAPAGPRDTDALDLEESSSSDHAERPPGPRRPERGPRGKGKARASQVKPGDSLPRRGPGATGIGTPAAGPGEERVGAAKASRWRGRQNREKRFTFVLAVVIGVFVVCWFPFFFTYTLTAVGCSVPRTLFKFFFWFGYCNSSLNPVIYTIFNHDFRRAFKKILCRGDRKRIV |
UniProt | P08913 |
Protein Data Bank | N/A |
GPCR-HGmod model | P08913 |
3D structure model | This predicted structure model is from GPCR-EXP P08913. |
BioLiP | N/A |
Therapeutic Target Database | T11448 |
ChEMBL | CHEMBL1867 |
IUPHAR | 25 |
DrugBank | BE0000289 |
Name | clonidine |
---|---|
Molecular formula | C9H9Cl2N3 |
IUPAC name | N-(2,6-dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine |
Molecular weight | 230.092 |
Hydrogen bond acceptor | 1 |
Hydrogen bond donor | 2 |
XlogP | 1.6 |
Synonyms | Tocris-0690 KBio2_000308 KBio3_001275 Lopac-C-7897 MN3L5RMN02 [ Show all ] |
Inchi Key | GJSURZIOUXUGAL-UHFFFAOYSA-N |
Inchi ID | InChI=1S/C9H9Cl2N3/c10-6-2-1-3-7(11)8(6)14-9-12-4-5-13-9/h1-3H,4-5H2,(H2,12,13,14) |
PubChem CID | 2803 |
ChEMBL | CHEMBL134 |
IUPHAR | 516 |
BindingDB | 50016897 |
DrugBank | DB00575 |
Structure | ![]() |
Lipinski's druglikeness | This ligand satisfies Lipinski's rule of five. |
Parameter | Value | Reference | Database source |
---|---|---|---|
N/A | N/A | DrugBank | |
EC50 | 8.1 nM | N/A | BindingDB |
EC50 | 8.128 nM | Bioorg. Med. Chem. Lett., (1994) 4:19:2317 | ChEMBL |
EC50 | 8.3 nM | PMID20925410 | BindingDB |
EC50 | 8.318 nM | PMID20925410 | ChEMBL |
EC50 | 10.0 nM | None | ChEMBL |
EC50 | 28.0 nM | PMID21129985 | BindingDB,ChEMBL |
EC50 | 30.0 nM | PMID22172308, PMID27265687 | BindingDB,ChEMBL |
EC50 | 30.2 nM | PMID27265687 | ChEMBL |
Emax | 51.0 % | PMID22172308 | ChEMBL |
Emax | 94.0 % | None | ChEMBL |
IC50 | 280.0 nM | DrugMatrix in vitro pharmacology data | ChEMBL |
Intrinsic activity | 0.9 - | PMID20925410 | ChEMBL |
Intrinsic activity | 41.0 % | PMID27265687 | ChEMBL |
Intrinsic activity | 53.0 % | PMID21129985 | ChEMBL |
Ki | 0.630958 - 63.0958 nM | PMID9824686, PMID9605427, PMID9760042 | IUPHAR |
Ki | 3.8 nM | PMID8784451, PMID8632424 | BindingDB,ChEMBL |
Ki | 7.9 nM | N/A | BindingDB |
Ki | 7.943 nM | Bioorg. Med. Chem. Lett., (1994) 4:19:2317 | ChEMBL |
Ki | 8.7 nM | PMID22750139 | BindingDB |
Ki | 8.71 nM | PMID22750139 | ChEMBL |
Ki | 28.0 nM | PMID27265687 | BindingDB,ChEMBL |
Ki | 31.6228 nM | PMID11082457 | PDSP,BindingDB |
Ki | 35.4813 nM | PMID11082457 | PDSP,BindingDB |
Ki | 50.1187 nM | PMID11082457 | PDSP,BindingDB |
Ki | 61.6595 nM | PMID9605427 | PDSP |
Ki | 61.66 nM | PMID9605427 | BindingDB |
Ki | 105.0 nM | DrugMatrix in vitro pharmacology data | ChEMBL |
Ki | 853.0 nM | PMID10715142 | BindingDB,ChEMBL |
zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417